HIF1A and atherosclerosis: Certainly, additional studies will be required to define the potential of the interplay between miR-199a-5p and hypoxia, HIF1 with lipid metabolism and key mediators such as ABCA1, LXR, which could be potentially exploited to therapeutically interfere with the progression of atherosclerosis and cardiovascular associated disease.